Lung Transplantation for Interstitial Lung Diseases and Pulmonary Hypertension

 

 Buy Article Permissions and Reprints

Abstract

Lung transplantation (LTx) is an established therapeutic option for patients with various end-stage lung diseases. Presently the worldwide procedural frequency is ∼ 3,200 per year. Unfortunately, the shortage of donor organs leads to approximately every sixth patient in Western countries dying before a donor organ is available. The most frequent underlying clinical indications for LTx are emphysema, pulmonary fibrosis, and cystic fibrosis. Worldwide, a recent analysis of all recipients reported that 23% had idiopathic pulmonary fibrosis (IPF) and 3% had pulmonary artery hypertension. In experienced centers, candidates for transplantation are chosen according to disease-specific factors after the exclusion of contraindications. However, there are several challenges for lung transplantation. The number of lung transplantations performed is limited by the supply of donor organs, and the long-term survival rates are still inferior compared with other forms of solid organ transplantation. Nevertheless, LTx offers a survival benefit in carefully selected patients with interstitial lung diseases and pulmonary hypertension.

• References

• 1 Simonneau G, Robbins IM, Beghetti M , et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl) S43-S54
  CrossrefPubMedGoogle Scholar
• 2 Kinder BW, Collard HR, Koth L , et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 2007; 176 (7) 691-697
  CrossrefPubMedGoogle Scholar
• 3 Christie JD, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation.. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31 (10) 1073-1086
  CrossrefPubMedGoogle Scholar
• 4 Boujoukos AJ, Martich GD, Vega JD, Keenan RJ, Griffith BP. Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant 1997; 16 (4) 439-448
  PubMedGoogle Scholar
• 5 Bando K, Keenan RJ, Paradis IL , et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg 1994; 58 (5) 1336-1342
  CrossrefPubMedGoogle Scholar
• 6 Kramer MR, Marshall SE, McDougall IR , et al. The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension. Transplant Proc 1991; 23 (1, Pt 2) 1215-1216
  PubMedGoogle Scholar
• 7 Levine SM, Jenkinson SG, Bryan CL , et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992; 101 (2) 401-405
  CrossrefPubMedGoogle Scholar
• 8 Reitz BA, Wallwork JL, Hunt SA , et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306 (10) 557-564
  CrossrefPubMedGoogle Scholar
• 9 Whyte RI, Robbins RC, Altinger J , et al. Heart-lung transplantation for primary pulmonary hypertension. Ann Thorac Surg 1999; 67 (4) 937-941 , discussion 941–942
  CrossrefPubMedGoogle Scholar
• 10 Kramer MR, Valantine HA, Marshall SE, Starnes VA, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol 1994; 73 (7) 494-500
  CrossrefPubMedGoogle Scholar
• 11 Pasque MK, Trulock EP, Kaiser LR, Cooper JD. Single-lung transplantation for pulmonary hypertension: three-month hemodynamic follow-up. Circulation 1991; 84 (6) 2275-2279
  CrossrefPubMedGoogle Scholar
• 12 Pasque MK, Trulock EP, Cooper JD , et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation 1995; 92 (8) 2252-2258
  CrossrefPubMedGoogle Scholar
• 13 Schulman LL, Leibowitz DW, Anandarangam T , et al. Variability of right ventricular functional recovery after lung transplantation. Transplantation 1996; 62 (5) 622-625
  CrossrefPubMedGoogle Scholar
• 14 Lupinetti FM, Bolling SF, Bove EL , et al. Selective lung or heart-lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies. Ann Thorac Surg 1994; 57 (6) 1545-1548 , 1549
  CrossrefPubMedGoogle Scholar
• 15 Thabut G, Christie JD, Ravaud P , et al. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med 2009; 151 (11) 767-774
  CrossrefPubMedGoogle Scholar
• 16 Christie JD, Edwards LB, Kucheryavaya AY , et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report—2011. J Heart Lung Transplant 2011; 30 (10) 1104-1122
  CrossrefPubMedGoogle Scholar
• 17 OPTN/SRTR 2010 Annual Data Report. 1–7-2011. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). http://www.srtr.org/annual_reports/2010/pdf/2010_SRTR_ADR.pdf
  PubMedGoogle Scholar
• 18 Weiss ES, Merlo CA, Shah AS. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data. J Am Coll Surg 2009; 208 (3) 400-409
  CrossrefPubMedGoogle Scholar
• 19 Lederer DJ, Wilt JS, D'Ovidio F , et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180 (9) 887-895
  CrossrefPubMedGoogle Scholar
• 20 Morrison EB, Gaffney FA, Eigenbrodt EH, Reynolds RC, Buja LM. Severe pulmonary hypertension associated with macronodular (postnecrotic) cirrhosis and autoimmune phenomena. Am J Med 1980; 69 (4) 513-519
  CrossrefPubMedGoogle Scholar
• 21 Thabut G, Mal H, Castier Y , et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003; 126 (2) 469-475
  CrossrefPubMedGoogle Scholar
• 22 Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011; 184 (7) 842-847
  CrossrefPubMedGoogle Scholar
• 23 De Meester J, Smits JM, Persijn GG, Haverich A. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 1999; 18 (6) 563-571
  CrossrefPubMedGoogle Scholar
• 24 Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351 (9095) 24-27
  CrossrefPubMedGoogle Scholar
• 25 Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009; 9 (7) 1640-1649
  CrossrefPubMedGoogle Scholar
• 26 King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164 (7) 1171-1181
  CrossrefPubMedGoogle Scholar
• 27 Raghu G, Collard HR, Egan JJ , et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183 (6) 788-824
  CrossrefPubMedGoogle Scholar
• 28 Orens JB, Estenne M, Arcasoy S , et al; Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25 (7) 745-755
  CrossrefPubMedGoogle Scholar
• 29 Navaratnam V, Ali N, Smith CJ, McKeever T, Fogarty A, Hubbard RB. Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?. Respir Med 2011; 105 (12) 1925-1930
  CrossrefPubMedGoogle Scholar
• 30 Lama VN, Flaherty KR, Toews GB , et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168 (9) 1084-1090
  CrossrefPubMedGoogle Scholar
• 31 Hook JL, Arcasoy SM, Zemmel D, Bartels MN, Kawut SM, Lederer DJ. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur Respir J 2012; 39 (2) 359-365
  CrossrefPubMedGoogle Scholar
• 32 Mura M, Porretta MA, Bargagli E , et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J 2012; 40 (1) 101-109
  CrossrefPubMedGoogle Scholar
• 33 Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129 (3) 746-752
  CrossrefPubMedGoogle Scholar
• 34 Gottlieb J, Rare Indications for Lung Transplantation. European Respiratory Society; 2011:332–340. Cordier JF. ed. European Respiratory Society Monograph 54
  Google Scholar
• 35 Hoeper MM, Andreas S, Bastian A , et al. Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011; 154 (Suppl. 01) S45-S53
  CrossrefPubMedGoogle Scholar
• 36 Conte JV, Gaine SP, Orens JB, Harris T, Rubin LJ. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. J Heart Lung Transplant 1998; 17 (7) 679-685
  PubMedGoogle Scholar
• 37 Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension. Chest 1998; 114 (5) 1269-1275
  CrossrefPubMedGoogle Scholar
• 38 Pielsticker EJ, Martinez FJ, Rubenfire M. Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transplant 2001; 20 (12) 1297-1304
  CrossrefPubMedGoogle Scholar
• 39 Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension: length of survival in patients referred for heart-lung transplantation. Chest 1987; 91 (5) 675-681
  CrossrefPubMedGoogle Scholar
• 40 Rich S, Levy PS. Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. Am J Med 1984; 76 (4) 573-578
  CrossrefPubMedGoogle Scholar
• 41 Benza RL, Miller DP, Gomberg-Maitland M , et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122 (2) 164-172
  CrossrefPubMedGoogle Scholar
• 42 Egan TM, Murray S, Bustami RT , et al. Development of the new lung allocation system in the United States. Am J Transplant 2006; 6 (5 Pt 2) 1212-1227
  CrossrefPubMedGoogle Scholar
• 43 Ley B, Ryerson CJ, Vittinghoff E , et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156 (10) 684-691
  CrossrefPubMedGoogle Scholar
• 44 Chen H, Shiboski SC, Golden JA , et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med 2009; 180 (5) 468-474
  CrossrefPubMedGoogle Scholar
• 45 Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, McGoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation 2010; 90 (3) 298-305
  PubMedGoogle Scholar
• 46 Fuehner T, Kuehn C, Hadem J , et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185 (7) 763-768
  CrossrefPubMedGoogle Scholar
• 47 Gottlieb J, Warnecke G, Hadem J , et al. Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med 2012; 38 (6) 968-975
  CrossrefPubMedGoogle Scholar